ZEAL — Zealand Pharma A/S Balance Sheet
0.000.00%
Last trade - 00:00
- DKK44.75bn
- DKK43.24bn
- DKK342.79m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,381 | 1,258 | 1,428 | 1,178 | 1,633 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 15.8 | 61.9 | 110 | 82.8 | 111 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,427 | 1,420 | 1,722 | 1,316 | 1,780 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 125 | 213 | 221 | 165 | 150 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1,600 | 1,762 | 2,068 | 1,540 | 1,980 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 195 | 355 | 334 | 195 | 285 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 357 | 533 | 1,140 | 724 | 387 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 1,243 | 1,229 | 928 | 816 | 1,593 |
Total Liabilities & Shareholders' Equity | 1,600 | 1,762 | 2,068 | 1,540 | 1,980 |
Total Common Shares Outstanding |